Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)-Reference-Cited by-同舟云学术

Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Published:2017-05-22 Issue:6 Volume:90 Page:881-887
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Sarno Giovanna¹²^ORCID,Lagerqvist Bo¹²,Olivecrona Göran³,Varenhorst Christoph¹²,Danielewicz Mikael⁴,Hambraeus Kristina⁵,Lindholm Daniel¹²,Råmunddal Truls⁶,Witt Nils⁷,James Stefan¹²

Affiliation:

1. Department of Medical Sciences; Cardiology and Uppsala Clinical Research Center, Uppsala University; Uppsala Sweden

2. UCR, Uppsala Clinical Research Center; Uppsala Sweden

3. Department of Cardiology; Lund University Hospital; Lund Sweden

4. Department of Cardiology; Karlstad Hospital; Karlstad Sweden

5. Department of Cardiology; Falun Lasarett; Falun Sweden

6. Department of Cardiology; Sahlgrenska University Hospital; Göteborg Sweden

7. Department of Cardiology; Södersjukhuset University Hospital; Stockholm Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference26 articles.

1. Drug-eluting stents: Caution and concerns for long-term outcome;Virmani;Coron Artery Dis,2004

2. Vascular responses to drug eluting stents: Importance of delayed healing;Finn;Arterioscler Thromb Vasc Biol,2007

3. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: The COMFORTABLE AMI randomized trial;Raber;Jama,2012

4. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial;Windecker;Lancet,2008

5. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: Final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial;Serruys;JACC Cardiovasc Interv,2013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents;Journal of Clinical Medicine;2023-10-24

2. Three-Year Clinical Outcomes of a Thin-Strut Biodegradable-Polymer Everolimus-Eluting Stent in Patients With Acute Coronary Syndrome;Journal of Cardiovascular Intervention;2023

3. Definition of Optimal Optical Coherence Tomography–Based Stent Expansion Criteria: In-Stent Minimum Lumen Area Versus Residual Stent Underexpansion;Circulation: Cardiovascular Interventions;2022-09

4. Impact of lipoprotein (a) on long-term outcome after percutaneous coronary intervention in the era of new generation drug-eluting stents;Journal of Cardiology;2022-08

5. Bioresorbable‐polymer Everolimus‐eluting Stents;Interventional Cardiology;2022-05-06